Both in Biotechnology
Century Therapeutics vs Eikon Therapeutics
Over the past year IPSC returned −9.0% and EIKN returned −63.0%; their daily moves had a correlation of 0.39.
IPSC −9.0% EIKN −63.0%Growth of $1, one year, split-adjusted
| Metric | IPSC | EIKN |
|---|---|---|
| Price | $1.52 | $5.55 |
| Market cap | $275.2M | $300.6M |
| Today | +2.70% | −2.29% |
| 1 month | +2.7% | −26.4% |
| 6 months | −33.6% | −46.0% |
| Year to date | +52.8% | — |
| 1 year | +160.7% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $119.7M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 72.8% | 99.9% |
| Short % of float | 23.4% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).